Topped up at 2.55 today, it touched the bottom trendline and looked like a good enough entry point to me. And as garykildey said no cause for concern if you're in for the longer term imo.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%